PDL BioPharma (PDLI) Reports Q3 EPS of $0.16; Suspends Guidance for FY07
Tweet Send to a Friend
PDL BioPharma (Nasdaq: PDLI) reported Q3 EPS of $0.16, 3 cents better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
